author-photo

Elena Biagioli

Mario Negri Institute for Pharmacological Research

37

Papers

577

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

The Glaucoma Italian Pediatric Study (GIPSy): the Long-term Effect of Topical Latanoprost on Central Corneal Thickness.

2020 Journal of Glaucoma
Show All
- Source
- Cite
- Save
Citations (1)
Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials according to brca mutational status

2019 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (34)
AtTEnd/ENGOT-en7: A multicenter phase III double-blind randomized controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

2019 Journal of Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (9)
EP814 TGFβ pathway activation is a predictor of progression free and overall survival in advanced high-grade serous ovarian cancer according to the surgical aggressiveness and rate of cytoreduction of different oncologic centers

2019
Show All
- Source
- Cite
- Save
Citations (0)
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.

2019 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint

2018 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (18)
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

2018 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (8)
1002TiPBAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resistant ovarian cancer

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Does tumor size in T1-T2 early breast cancer (EBC) still have a prognostic role?

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)